Literature DB >> 34982355

Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer's Disease Induced by Aluminum.

Xiaocheng Gao1, Ping Zhang1, Jianping Chen1, Lan Zhang1, Nan Shang1, Jin Chen1, Rong Fan1, Yanhong Wang1, Tao Huang1, Qiao Niu1, Qinli Zhang2.   

Abstract

Aluminum (Al) is considered one of the environmental risk factors for Alzheimer's disease (AD). The present study aims to establish a zebrafish AD model induced by Al and explore if necrostation-1 (Nec-1), a specific inhibitor of necroptosis, is effective in relieving learning and memory deficits in the zebrafish AD models. We treated adult zebrafish with aluminum trichloride at various doses for 1 month, followed by a T-maze test to evaluate learning and memory performance. Al concentration, levels of acetylcholine (Ach), and AD-related protein and gene expression in the brain tissue were evaluated in the zebrafish AD models. Our results demonstrated that in the brain tissue of Al-treated zebrafish, Al accumulated, Ach levels decreased, and AD-related genes and proteins increased. As a result, the learning and memory performance of Al-treated zebrafish was impaired. This suggested that a zebrafish AD model was established. To test the effect of Nec-1 on the zebrafish AD model, we added Nec-1 into the culture medium of the Al-treated adult zebrafish. The results demonstrated that Nec-1 could relive the learning and memory deficits, enhance Ach levels and the numbers of neural cells, and impact necroptosis-related gene expression. We concluded that Nec-1 could reverse Al-induced learning and memory impairment and had potential theoretical value in the zebrafish AD model.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aluminum; Alzheimer’s disease; Necroptosis; Necrostatin-1; Zebrafish

Mesh:

Substances:

Year:  2022        PMID: 34982355     DOI: 10.1007/s12640-021-00463-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  79 in total

1.  Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.

Authors:  Annadora J Bruce-Keller; Sunita Gupta; Alecia G Knight; Tina L Beckett; Jessica M McMullen; Paulina R Davis; M Paul Murphy; Linda J Van Eldik; Daret St Clair; Jeffrey N Keller
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

2.  Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats.

Authors:  Azza A Ali; Hebatalla I Ahmed; Sahar A Khaleel; Karema Abu-Elfotuh
Journal:  Physiol Behav       Date:  2019-06-06

Review 3.  Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer's disease and age-related neurodegeneration.

Authors:  Stephen C Bondy
Journal:  Neurotoxicology       Date:  2015-12-12       Impact factor: 4.294

4.  Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.

Authors:  Antonella Caccamo; Ramona Belfiore; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2018-04-05       Impact factor: 4.673

5.  Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

Authors:  Alexandre Bejanin; Daniel R Schonhaut; Renaud La Joie; Joel H Kramer; Suzanne L Baker; Natasha Sosa; Nagehan Ayakta; Averill Cantwell; Mustafa Janabi; Mariella Lauriola; James P O'Neil; Maria L Gorno-Tempini; Zachary A Miller; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

6.  Higher brain BDNF gene expression is associated with slower cognitive decline in older adults.

Authors:  Aron S Buchman; Lei Yu; Patricia A Boyle; Julie A Schneider; Philip L De Jager; David A Bennett
Journal:  Neurology       Date:  2016-01-27       Impact factor: 9.910

7.  Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy.

Authors:  James B Whitney; So-Yon Lim; Christa E Osuna; Jessica L Kublin; Elsa Chen; Gyeol Yoon; Po-Ting Liu; Peter Abbink; Erica N Borducci; Alison Hill; Mark G Lewis; Romas Geleziunas; Merlin L Robb; Nelson L Michael; Dan H Barouch
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

8.  Reduced Cerebral Glucose Uptake in an Alzheimer's Rat Model With Glucose-Weighted Chemical Exchange Saturation Transfer Imaging.

Authors:  Peidong Chen; Zhiwei Shen; Qianqian Wang; Bingna Zhang; Zerui Zhuang; Jiefen Lin; Yuanyu Shen; Yanzhi Chen; Zhuozhi Dai; Renhua Wu
Journal:  Front Aging Neurosci       Date:  2021-03-17       Impact factor: 5.750

Review 9.  Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications.

Authors:  Liyuan Cao; Wei Mu
Journal:  Pharmacol Res       Date:  2020-11-09       Impact factor: 7.658

View more
  1 in total

Review 1.  The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease.

Authors:  Avinash Shenoy; Meheli Banerjee; Archana Upadhya; Siddhi Bagwe-Parab; Ginpreet Kaur
Journal:  Front Behav Neurosci       Date:  2022-06-13       Impact factor: 3.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.